Range Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Sell
2,243
-12,437
-85% -$1.64M 0.08% 187
2026
Q1
$2.05M Sell
14,680
-203
-1% -$28.4K 0.69% 51
2025
Q4
$1.83M Buy
14,883
+1,635
+12% +$199K 0.63% 51
2025
Q3
$1.47M Sell
13,248
-334
-2% -$38K 0.53% 60
2025
Q2
$1.51M Sell
13,582
-2,369
-15% -$252K 0.59% 57
2025
Q1
$1.79M Buy
15,951
+5,325
+50% +$549K 0.79% 37
2024
Q4
$982K Buy
10,626
+7,868
+285% +$708K 0.45% 72
2024
Q3
$231K Sell
2,758
-5,254
-66% -$401K 0.32% 71
2024
Q2
$550K Sell
8,012
-5,021
-39% -$335K 0.28% 104
2024
Q1
$955K Buy
13,033
+3,634
+39% +$279K 0.5% 67
2023
Q4
$761K Sell
9,399
-95
-1% -$7.39K 0.46% 72
2023
Q3
$711K Sell
9,494
-256
-3% -$19.7K 0.47% 73
2023
Q2
$751K Sell
9,750
-3,948
-29% -$315K 0.48% 76
2023
Q1
$1.14M Sell
13,698
-923
-6% -$76.4K 0.74% 49
2022
Q4
$1.26M Sell
14,621
-1,415
-9% -$112K 0.86% 37
2022
Q3
$989K Buy
16,036
+9
+0.1% +$568 0.76% 51
2022
Q2
$991K Sell
16,027
-223
-1% -$13.8K 0.72% 57
2022
Q1
$966K Buy
16,250
+1,373
+9% +$87.8K 0.62% 62
2021
Q4
$1.08M Sell
14,877
-31
-0.2% -$2.13K 0.71% 52
2021
Q3
$1.04M Buy
14,908
+243
+2% +$17.1K 0.75% 53
2021
Q2
$1.01M Buy
14,665
+4,439
+43% +$296K 0.75% 52
2021
Q1
$661K Buy
+10,226
New +$659K 0.6% 71

Other funds holding GILD

Range Financial Group's GILD Position: Q2 2026 in Review

Range Financial Group reduced its Gilead Sciences (GILD) stake by 85% in Q2 2026, selling an estimated $1.64M and leaving 2,243 shares worth $283K. The position accounts for 0.08% of the portfolio, ranked #187.

Range Financial Group first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.05M in Q1 2026. 1,095 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Range Financial Group held 2,243 shares of Gilead Sciences worth $283K as of Q2 2026.
  • Range Financial Group sold 12,437 Gilead Sciences shares in Q2 2026, an estimated $1.64M.
  • Gilead Sciences made up 0.08% of Range Financial Group's portfolio in Q2 2026, its #187 holding.
  • Range Financial Group first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
  • Range Financial Group's Gilead Sciences position peaked at $2.05M in Q1 2026.
  • 1,095 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.